Hyris CE-IVD marked test for COVID human diagnostic "bKIT Virus Finder COVID-19" is at the core of the signature Article "Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection", from the Department of Laboratory Medicine of the National Institute for The Study and Treatment of Cancer IRCCS "Fondazione G Pascale" (IRCCS Pascale), of Naples (Italy)

Hyris bKIT Virus Finder Covid-19 is the first commercially available, rapid COVID-19 medical device approved by Health Canada for point-of-care human testing. Exclusively distributed by Songbird Life Science, it is fast becoming the preferred choice of industry leaders across Canada.

Hyris bCUBE based test kit is the only authorised medical device approved for human tests in Point of Care currently commercially available in Canada. Hyris Ltd. now focuses on supporting Canada in fully facing the new virus escalation.

Hyris Ltd first ranking for the Regione Lombardia COVID-19 Research fund with the project: COVES – Sviluppo e validazione di una metodica rapida per la rilevazione di SARS-CoV-2 su superfici ambientali

We are proud of our last result, a publication on Immunological Reviews of the paper “Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment”.

Toronto based Purity-IQ Inc., has partnered exclusively with Hyris, a leader in Artificial Intelligence applications for advanced diagnostics with offices in London, Milan and Singapore, to support their business expansion in the Americas.

The identification of infected surfaces is a key step to fight COVID-19 spreading.  Thanks to our new kit, the detection of COVID-19 Environmental contamination is now easy, fast and accurate.